| MSD Merck Sharp & Dohme AG - Janumet XR 100 mg/1000 mg, Filmtabletten | | 65052 | | 03 | | Janumet XR 100 mg/1000 mg | | Filmtabletten | | A10BD07 | | Metformine et Sitagliptine | | 30.07.2014 | | |
| | Composition | | metformini hydrochloridum 1000 mg, sitagliptini phosphas monohydricus 128.5 mg corresp. sitagliptinum 100 mg, povidonum K 29-32, hypromellosum, silica colloidalis anhydrica, natrii stearylis fumaras corresp. natrium 1.77 mg, E 310, macrogolum 3350, kaolinum leve, Überzug: hypromellosum, hydroxypropylcellulosum, E 171, E 132, cera carnauba, pro compresso obducto. | | Packungsbestandteile | | Filmtabletten | | | | | Principe actif | Concentr. |
|---|
| Metformini Hydrochloridum | 1000 mg | | Sitagliptini Phosphas Monohydricus | 128.5 mg correspond Sitagliptinum 100 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Metformini Hydrochloridum | 1000 mg | | Sitagliptinum | 100 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Cera Carnauba | | | | E 132 | | color. | | E 171 | | color. | | E 310 | | | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Kaolinum Leve | | | | Macrogolum | 3350 | | | Natrii Stearylis Fumaras | | | | Povidonum K | 29-32 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 28 Tablette(n) | 20.42 | 38.30 | B | LS | Oui | | 009 | 84 Tablette(n) | 60.35 | 81.15 | B | LS | Oui |
|
|
